|
|
Post Office Box 14087
Research Triangle Park, NC 27709 USA
phone:919 313 1290
fax:
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.orieltherapeutics.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Drug delivery technology for treating respiratory and pulmonary diseases. |
|
| Management |
| RICHARD FULLER, M.D., Ph.D., Chief Executive Officer; PAUL J. ATKINS, Ph.D., President & Chief Operating Officer; BRUCE E. LOWERY, Vice President of Finance; DAN M. DEATON, Director of Product Development; CHARLES E. MADER, Ph.D., Director of Analytical and Formulation Development |
| |
|
|
| |
|
| Keywords |
| drug delivery, powder, respiratory, diseases, pharmaceuticals, pulmonary, DrugDelivery |
|
|
|
| Description |
|
Oriel Therapeutics develops technology for drug delivery to the lungs to better treat respiratory and pulmonary diseases. |
|
| Technology / Differentiation |
| Oriel Therapeutics is developing a dry powder inhaler (DPI) with its own energy source to improve the health maintenance of those suffering from asthma and Chronic Obstructive Pulmonary Disease (COPD). In the future, this technology may also be used to deliver medications that currently are delivered via injections. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members